Scipher Medicine

Scipher announced a collaboration with Maxymune Therapeutics to capitalize on Scipher’s target ranking capabilities across research & development programs. Scipher will provide target ranking & engagement optimization services through its hosted platform. sciphermedicine.com/scipher-medici…

Scipher announced the launch of ClinicalTrialRank.com, an AI platform that predicts clinical trial failure with unprecedented accuracy, enabling biopharma and investors to make more informed decisions and avoid investing in therapies destined to fail. sciphermedicine.com/scipher-medici…

Scipher and @Savant_Bio announced an expanded partnership to build the most advanced clinicogenomic dataset in RA, aiming to generate insights to support academic research, clinical trial design, therapeutic strategy, and RWE generation. #PrecisionMedicine sciphermedicine.com/scipher-and-sa…

At @eular_org 2025, Scipher unveiled a new, AI-driven approach to help doctors better evaluate if an RA treatment is working. This “RA Response Calculator” offers a more accurate way to determine whether someone is improving on their current therapy. sciphermedicine.com/scipher-medici…

Scipher announced an alliance with Grupo Amarey to expand the reach of its precision diagnostic, @PrismRAtest. This marks Scipher’s first international expansion, bringing personalized medicine to patients with RA in Latin America. #PrecisionMedicine sciphermedicine.com/scipher-medici…

Scipher announced a collaboration with a top global pharma company, aiming to enhance clinical trials by incorporating @PrismRAtest. PrismRA analyzes a patient’s molecular profile, enabling a more precise understanding of patient populations.#Clinicaltrial sciphermedicine.com/collaboration-…

@ScipherMedicine & InnoSIGN announce a partnership to advance the treatment of complex immune-mediated diseases. The collaboration will leverage Scipher’s RNA sequencing data, which will be analyzed using InnoSIGN’s proprietary pathway platform. sciphermedicine.com/scipher-medici…

Scipher & @KytheraLabs announced a partnership to advance rheumatology treatment discovery by integrating Scipher’s real-world clinical & genomic data insights with Kythera’s enriched, high-fidelity, multi-source data assets. #PrecisionMedicine sciphermedicine.com/scipher-medici…

Scipher & @Roivant announced a partnership to advance rheumatology drug discovery & development by integrating Scipher’s real-world clinical & genomic data insights into Roivant’s research & development efforts by leveraging the data from @PrismRAtest. sciphermedicine.com/scipher-medici…

Scipher and @OmnyHealth announced a partnership to advance precision medicine for immunology, integrating transcriptomic data from Scipher with OMNY Health's vast EHR network that reaches more than 80 million patients. #PrecisionMedicine #AutoimmuneDisease sciphermedicine.com/omny-health-an…

Scipher Medicine and @AtroposHealth announced a strategic partnership to accelerate precision medicine and expand the Immunology Multimodal Network, advancing shared decision-making for patients with rheumatoid arthritis. sciphermedicine.com/scipher-medici…

A new publication from Scipher Medicine in the Journal of Molecular Diagnostics details new approach to discover treatment-response-predicting biomarkers for complex diseases. sciphermedicine.com/scipher-medici…

This week Scipher Medicine presented at EULAR 2024 in Vienna, Austria. The technology behind @PrismRAtest and the impact that the test is having on treatment selection in RA is pushing precision medicine forward for autoimmune patients. sciphermedicine.com/scipher-medici…

Scipher’s CEO & President, Reg Seeto, CTO, Slava Akmaev, and Ingo Chakarvarty are looking forward to joining over 500 public & private healthcare companies, investors, and VCs at this year’s Jefferies Global Healthcare Conference. #JefferiesHealthcare #PrecisionMedicine

Join us at BIO 2024 June 3-6 in San Diego, CA where Scipher’s executive leadership team will be meeting with leaders across the industry to showcase our unique Spectra Platform and the invaluable strides its making in precision medicine. #BIO2024 #PrecisionMedicine

This week Scipher’s own Uday Shanthamallu presented a poster at Digestive Disease Week in Washington DC. #PrecisonMedicine #AutoimmuneDisease #DDW2024 #ulcerativecolitis Link: sciphermedicine.com/identifying-tn…

Our own, Sherry Guardiano, DO, MBA, presented an abstract at the Congress of Clinical Rheumatology conference in Destin, FL on Friday. PrismRA is proving its value in the rheumatology community as a keystone precision medicine test, guiding RA treatment decisions to get more patients to low disease activity or remission, sooner. #precisionmedicine #autoimmunedisease #rheumatoidarthritis

Scipher Medicine is proud to welcome Reginald Seeto as our new President and CEO. His unique background and vision for the future are the perfect combination for Scipher’s next phase of growth. Welcome Reg! sciphermedicine.com/dr-reginald-se… #precisionmedicine #leadership

Today we are launching an updated look & feel for Scipher Medicine. The brighter color pallet aligns with our vision of hope and using our network science to help those who are suffering in silence. #PrecisionMedicine #autoimmunedisease